Oesophageal narrowing during combination chemotherapy in Ewing's sarcoma: Is vincristine a culprit?

BMJ Case Reports
Kunal DasNitika Agrawal

Abstract

Vincristine is a widely used chemotherapeutic agent in paediatric oncology. A 7-year-old boy was diagnosed with non-metastatic Ewing's sarcoma of the pelvis. He was started on chemotherapy with vincristine-cyclophosphamide-adriamycin alternate with ifosfamide-etoposide. He developed recurrent vomiting after three cycles of chemotherapy. Evaluation showed oesophageal stricture involving the middle and lower third part. Biopsy was non-conclusive. His symptoms improved with dilatation. A chemotherapy-induced neuropathic dysmotility was suspected, and his chemotherapy was continued with serial dilatation. Vincristine, being neurotoxic, was suspected to be the reason of this morbidity. His need of dilatation decreased, and symptoms improved remarkably after completion of chemotherapy.Vincristine-induced oesophageal dysmotility is a rare side effect. There is no consensus on management. Omission of this effective agent in such situation is debatable.

References

Nov 1, 1978·Southern Medical Journal·R C Chisholm, S B Curry
Jan 1, 1986·Journal of Neuro-oncology·D V JacksonH B Muss
Jan 13, 2001·Japanese Journal of Clinical Oncology·W S WangP M Chen
Dec 9, 2008·Pediatric Blood & Cancer·Alisha Kassam, Karen Mandel
Aug 30, 2017·ACG Case Reports Journal·Daniel SedhomVinod Rustgi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.